ALS stem cell study halted after just one patient
Disease control
Terminated
This study tested a single dose of STR04, made from a patient's own bone marrow stem cells, for amyotrophic lateral sclerosis (ALS). Only one person enrolled before the study was stopped early. The goal was to see if the treatment was safe and could slow the disease, but no concl…
Phase: PHASE2 • Sponsor: New England Cell Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC